SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

CPO Biologiques

» Start this Course
(Practice similar questions for free)
Question:

Canakinumab (Ilaris)

Author: Natalia Abesada



Answer:

Anti IL1. Ind: Syndrome de fievres periodiques, Maladie de Still, arthite juvenile idiopatique systemique, Arthrite goutteuse.


0 / 5  (0 ratings)

1 answer(s) in total